Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Cetuximab can cause eyelash growth, which is rare but manageable.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

The research identified genes that explain why some sheep have curly wool and others have straight wool.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Epithelial-mesenchymal interactions control hair growth cycles through specific molecular signals.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

A substance called epidermal growth factor helps increase the growth of important hair follicle cells by activating a specific cell communication route.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

TGF-β signaling is essential for new hair growth after wounds.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Skin reactions from cancer treatments might predict how well the treatments work.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Allopregnanolone changes gene expression in glioblastoma cells.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Two microRNAs affect hair follicle development in sheep by targeting specific genes.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Epidermal stem cells show promise for treating orthopedic injuries and diseases.

Removing centrosomes from skin cells leads to thinner skin and stops hair growth, but does not greatly affect skin cell differentiation.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.